To further advance oncology with technology, the biotech startup is setting up a 3D cancer pathology lab in the Phoenix-based
YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar, that is now interchangeable [1] Interchangeable designation
Addiction Recovery Expert and Podcast Host Richard Taite to Release A Special Episode of We're Out Of Time in Recognition
FRANKILN, Mass., April 14, 2025 /PRNewswire/ -- Amsino has taken a significant step forward in our mission to advance healthcare
TORRANCE, Calif., April 14, 2025 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in
… through the Minnesota Department of Agriculture (MDA) aimed at … Minnesota agricultural products.
VERONA, WI, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Commercial Recreation Specialists (CRS), a leading provider of innovative recreation solutions,
HERITAGE, GLAMOUR, AND ETHEREAL BEAUTY WILL CONVERGE IN THE GOLDEN TRIANGLE CITY OF JAIPUR AND RANTHAMBORE NATIONAL PARK PARIS, April
HERITAGE, GLAMOUR, AND ETHEREAL BEAUTY WILL CONVERGE IN THE GOLDEN TRIANGLE CITY OF JAIPUR AND RANTHAMBORE NATIONAL PARK PARIS, April
Major capital improvement projects showcase Aspen One's ongoing commitment and long-term investment in the world-class Aspen Snowmass experience ASPEN, Colo.,